The requirements for assessing irritation is now moved from ISO 10993-10 to ISO 10993-23 and with this new standard comes the inclusion of in vitro irritation testing. As we move further to reduce animal testing and incorporate the 3 R’s (replace, reduce, refine) into biocompatibility assessment for medical devices, this is a critical turning point. Join us for an intense and informative discussion on this standard and learn what steps to take to incorporate this testing into your biocompatibility program.
• Review of the in vitro testing method
• When to pursue in vitro or in vivo testing
• How to transition from in vivo to in vitro testing
• Current regulatory acceptance
Presenters: Audrey Turley & Dr. Sophie Michel
